Predrag Bogavac, now Country Head, OGM Serbia and Montenegro, a.i. Oncology General Manager Bulgaria and Macedonia at Novartis, shares the highlights of the past two years as Country Head of Novartis Serbia and Montenegro, his responsibilities as Head of Oncology, the challenges within the Serbian market, particularly surrounding reimbursement, and the exciting story of how he turned the affiliate around in two years with the expectation to become a top three affiliate within the country over the next few years.
Mr. Bogavac, having previously been head of the Business Unit Novartis Oncology, you were promoted to Country Head of Novartis Serbia and Montenegro in June 2015. What priorities and goals did you set for yourself when taking the position?
"Novartis is a name that carries a lot of weight here as a well-regarded and incredibly well-recognized company, so we are able to hire the best people."
